Covered recipient · General Payments record
LAUREN KIRYAKOZA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$2,566.33
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,551.48 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $415.47 | 4 |
| Sight Sciences, Inc. | $326.32 | 3 |
| Astellas Pharma US Inc | $158.71 | 1 |
| ABBVIE INC. | $147.12 | 2 |
| Genentech USA, Inc. | $125.00 | 1 |
| Alimera Sciences, Inc. | $124.05 | 1 |
| Regeneron Healthcare Solutions, Inc. | $119.70 | 1 |
| Amgen Inc. | $116.46 | 1 |
| Carl Zeiss Meditec USA, Inc. | $18.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $144.47 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104081330 | CMS |
| ABBVIE INC. | $2.65 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104081332 | CMS |
| Alcon Vision LLC | $131.84 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110702564 | CMS |
| Alcon Vision LLC | $138.61 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110702566 | CMS |
| Alcon Vision LLC | $110.21 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110702562 | CMS |
| Alcon Vision LLC | $34.81 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110702560 | CMS |
| Alimera Sciences, Inc. | $124.05 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092834219 | CMS |
| Amgen Inc. | $116.46 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620884 | CMS |
| Astellas Pharma US Inc | $158.71 | 09/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139402257 | CMS |
| Carl Zeiss Meditec USA, Inc. | $18.65 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153260092 | CMS |
| Genentech USA, Inc. | $125.00 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133052069 | CMS |
| Regeneron Healthcare Solutions, Inc. | $119.70 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114088855 | CMS |
| Sight Sciences, Inc. | $141.04 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928119 | CMS |
| Sight Sciences, Inc. | $67.68 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928115 | CMS |
| Sight Sciences, Inc. | $117.60 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928117 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.